This document collects and analyzes the data on the evolution of COVID-19, collected by the Johns Hopkins University and published daily by the European Documentation Center of Almeria during the year 2020. On January 24, 2020 France reported the first case of COVID-19, being the first case, being the first known case of COVID-19 in […]
Read MoreEU urges AstraZeneca to explain vaccine delivery delays
▶️ Watch the press conference by Commissioner @SKyriakidesEU on vaccine deliveries and on the export transparency scheme. #StrongerTogether https://t.co/iczvKiAiRm — European Commission 🇪🇺 (@EU_Commission) January 25, 2021 Last Friday, the company AstraZeneca surprisingly informed the Commission and the European Union Member States that it intends to supply considerably fewer doses in the coming weeks than […]
Read MoreCommission concludes exploratory talks with Valneva to secure a new potential vaccine
The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. This finalisation […]
Read MoreTorrecárdenas: the only hospital in Andalusia participating in the FOCUS program
After a selection process, Torrecárdenas University Hospital will participate in the implementation of the FOCUS program. The FOCUS program has been underway since 2010 and it aims to provide early diagnosis of infections such as HIV and Hepatitis C in hospitals and health centers. This is possible thanks to the agreement between the Andalusian Health […]
Read MoreEMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human […]
Read MoreEuropean Commission authorises second safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed […]
Read MoreEuropean Commission authorises first safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency […]
Read MoreThe Council and the European Parliament agree provisionally on the EU4Health programme for 2021-2027
The German presidency of the Council and the European Parliament reached a provisional deal on the EU4Health programme for 2021-2027. With a budget of EUR 5.1 billion, the new reinforced programme provides a strong basis for Union action in the health field based on lessons learned during the COVID-19 pandemic. It comes at a time […]
Read MoreWaging war against SARS-CoV-2 with Europe’s most powerful supercomputers
Searching for new COVID-19 treatments, an EU-funded project conducted a supercomputing experiment to study the interaction of over 70 billion antiviral molecules with SARS-CoV-2 proteins. A huge molecular computation experiment was recently conducted to identify new treatments against the SARS-CoV-2 virus. Run by the EU-funded EXSCALATE4CoV project, the experiment is believed to be the most […]
Read More